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a b s t r a c t
To assess the association between influenza immunization and subsequent diagnosis of group A strep-
tococcus (GAS)-illness in Army recruits during influenza seasons 2002–2006. A case–control study was
employedwith cases as traineeswithoutpatientGASdiagnosis (ICD-9-CMcodes: 034.0, 035, 038.0, 041.01,
320.2, 390–392, 482.31) during the influenza season, and controls as traineeswithnooutpatientGASdiag-
nosis during the influenza season. Primary exposure was influenza immunization during 1st September
to 30th April of each season. Estimated protective effects of influenza immunization against GAS-illness
ranged from50% to 77%. A strongprotective effectwas suggested for Army trainee influenza immunization
on the diagnosis of GAS-illness.
© 2008 Elsevier Ltd. All rights reserved.
1. Introduction
GroupA streptococcus (GAS) infections are often asymptomatic;
and of those that are clinically significant, most are expressed as
acute, febrile tonsillo-pharyngitis (i.e., strep throat) that is tran-
siently debilitating [1]. However, some virulent GAS strains cause
invasive diseases that can be severe (e.g., peritonsillar abscess) and
even life threatening (e.g., pneumonia, necrotizing fasciitis, toxic
shock). Finally, some “rheumatogenic” strains of GAS have delayed
clinical effects that are acutely debilitating (e.g., acute rheumatic
fever) and often chronically disabling (e.g., valvular heart disease)
[2–4].
Since the 1950s, at various military training installations, ben-
zathine penicillin G (BPG) has been given to non-allergic trainees
before they begin recruit training. This process of tandem pro-
phylaxis (administering prophylaxis to new incoming recruits) is
designed to prevent the introduction of virulent strains of GAS into
recruit camps and to protect new recruits fromacquiringGAS infec-
tions during the first few weeks of training [3,4]. Although BPG is
effective in reducing the risk forGAS infection, continuedoutbreaks
highlight the need for additional preventive measures.
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New military recruits are a sample of the young adult popula-
tion of the United States and its territories who enter the training
installation on a daily basis. Therefore, numerous and varied res-
piratory pathogens are continuously ‘seeded’ into, and co-circulate
in, recruit populations, particularly during the fall-winter seasons.
Co-circulating respiratory pathogens may interact through many
mechanisms. The most studied and best-documented interactions
are between influenza and bacterial respiratory pathogens, includ-
ing GAS [5–8]. Not surprisingly, during past influenza pandemics,
streptococcal pneumonias caused a substantial number of deaths,
including among young adults [5].
To counter the threats of influenza and GAS-related diseases,
all new recruits are immunized with the current year’s influenza
vaccine at all military installations, and routinely administered
BPG prophylaxis against GAS at Forts Benning, Leonard Wood, and
Sill, beginning basic combat training (BCT). The aim of the current
study was to assess the effects, if any, of influenza immunization
on GAS-related illnesses, in perennially high risk settings and sea-
sons, using routinely collected surveillance data. To address this
aim, a case–control study design was employed, in which strepto-
coccal illnesses diagnosed among U.S. Army traineeswere assessed
in relation to their records of influenza immunization status in one
of the four recent influenza seasons.
2. Methods
The surveillance period encompassed four influenza seasons
defined as 1st September to 30th April of 2002–2003, 2003–2004,
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2004–2005, and 2005–2006. The surveillance population included
all active component members of the U.S. Army who entered as
trainees anytime during the surveillance period at a BCT site: Fort
(Ft.) Benning, GA; Ft. Jackson, SC; Ft. Knox, KY; Ft. Leonard Wood,
MO; or Ft. Sill, OK. Trainees were followed from entry into train-
ing until 30th April of any given year. All study data were captured
from theDefenseManagement Surveillance System (DMSS), a pub-
lic health surveillance database that includes routinely collected
data on all medical encounters at military treatment facilities, as
well as demographic data for military service members [9].
A case was defined as the occurrence of at least one outpa-
tient diagnosis of a GAS-related illness (ICD-9-CM codes: 034.0,
035, 038.0, 041.01, 320.2, 390–392, 482.31), a minimum of 30 days
(the estimated protective effect from a single dose of BPG) after
the start of BCT [10]. The latter criterion was employed to avoid
bias that may be introduced into the study results due to the selec-
tive administration of BPG at Fts. Benning, Leonard Wood, and Sill.
To note, other evidence suggests inadequate serum levels of BPG
after 14 days of administration [11]. However, identical resultswere
produced when repeating our analysis using a shorter window of
14 days. Each case was matched to a maximum of four trainees
with no outpatient GAS-related illness diagnosis (i.e., ‘controls’),
by unit identification code (UIC), a code specific to each BCT site
and individual training unit.
Exposure was defined as the receipt, or the lack thereof, of an
influenza immunization aminimumof 14 days (the estimated time
to development of protective antibodies after immunization) prior
to the date of diagnosis [12]. As multiple vaccines are typically
administered to all new recruits, trainees with no documented
vaccinations were excluded from the study to minimize misclas-
sification due to missing records (n=5, 400, 3.7% of records). To
note, BCT is a 9-week training program and is the recruits’ first
encounter at amilitary installation/post as amilitary servicemem-
ber. An influenza immunization administered to a recruit would
have occurred at a BCT post.
Statistical analysis was performed using SAS version 9.1.3 (SAS
Institute, Cary, NC). Cases and controls were assessed with respect
to demographic/military characteristics and exposure to influenza
immunization, by influenza season, usingMcNemar’s2 tests. Con-
ditional logistic regression, matched by UIC, was used to evaluate
the effect of influenza immunization adjusted for independent
predictors of GAS-illness and/or influenza vaccination reported in
the literature. Covariates included age, gender, and month of entry
into service (proxy for total number of recruits on post) [13–15].
P<0.05 for a two-tailed testwas considered statistically significant.
3. Results
One thousand and ninety-eight GAS-illness cases and 4370 con-
trolswere identifiedover the2002 through2006 influenza seasons.
Across seasons, the median of the distribution of months in which
GAS-related illnesses was documented among the unexposed
recruits (i.e., unimmunized), December, was severalmonths earlier
than that documented among the exposed recruits (i.e., immu-
nized), February. Stratified by season, GAS cases had a significantly
lower odds than controls to have received an influenza immuniza-
tion in both crude and adjusted (i.e., for age, gender, month of entry
into military service, and UIC) analyses (Table 1). The estimated
protective effects of influenza immunization against GAS-illness
ranged from 50% (2002–2003 season) to 77% (2005–2006 season).
Table 1
Crude and adjusted odds ratio (OR) for GAS-illness to have received influenza vaccine, by influenza seasona
Influenza season Influenza vaccine GAS cases n (%) Controls n (%) OR (95% CI) Adjusted OR (95% CI)b
2002–2003 Yes 152 (53.0) 715 (62.9) 0.59 (0.44–0.80) 0.50 (0.37–0.68)
No 135 (47.0) 421 (37.1) Reference Reference
2003–2004 Yes 251 (72.1) 1215 (87.9) 0.33 (0.25–0.45) 0.26 (0.19–0.36)
No 97 (27.9) 168 (12.2) Reference Reference
2004–2005 Yes 112 (59.3) 633 (83.7) 0.22 (0.15–0.32) 0.14 (0.09–0.22)
No 77 (40.7) 123 (16.3) Reference Reference
2005–2006 Yes 198 (72.3) 971 (88.7) 0.25 (0.17–0.37) 0.23 (0.15–0.35)
No 76 (27.7) 124 (11.3) Reference Reference
Note: CI, confidence interval; GAS, group A streptococcus; OR, odds ratio; UIC, unit identification code.
a Case defined as at least one occurrence of ICD-9-CM codes 034.0, 035, 038.0, 041.01, 320.2, 390–392, 482.31.
b Adjusted for sex, age, month of service entry, and UIC.
Table 2
Crude and adjusted odds ratio for GAS-illness over four influenza seasonsa
Characteristic GAS cases (n=1098) n (%) Controls (n=4370) n (%) OR (95% CI) Adjusted OR (95% CI)b
Influenza Yes 713 (64.9) 3534 (80.9) 0.40 (0.35–0.47) 0.34 (0.29–0.40)
Vaccine No 385 (35.1) 836 (19.1) Reference Reference
Sex Male 912 (83.1) 3530 (80.8) 1.22 (1.00–1.49) 1.28 (1.04–1.57)
Female 186 (16.9) 840 (19.2) Reference Reference
Age 17–19 576 (52.5) 2139 (48.9) 1.73 (1.09–2.74) 1.62 (1.01–2.59)
20–24 435 (39.6) 1667 (38.2) 1.67 (1.05–2.66) 1.54 (0.96–2.48)
25–29 65 (5.9) 425 (9.7) 0.98 (0.58–1.65) 0.89 (0.52–1.52)
30–35 22 (2.0) 139 (3.2) Reference Reference
Influenza 2002–2003 287 (26.1) 1136 (26.0) 1.00 (0.79–1.26) 0.80 (0.63–1.03)
Season 2003–2004 348 (31.7) 1383 (31.7) 1.00 (0.80–1.24) 1.09 (0.87–1.38)
2004–2005 189 (17.2) 756 (17.3) 1.00 (0.78–1.28) 0.92 (0.71–1.19)
2005–2006 274 (24.9) 1095 (25.1) Reference Reference
Note: CI, confidence interval; GAS, group A streptococcus; OR, odds ratio; UIC, unit identification code.
a Case defined as at least one occurrence of ICD-9-CM codes 034.0, 035, 038.0, 041.01, 320.2, 390–392, 482.31.
b Adjusted for sex, age, season, month of service entry, and UIC.
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Collapsed over the four influenza seasons considered (Table 2),
GAS cases had a 66% lower odds of having received an influenza
immunization than controls (adjusted odds ratio [aOR] 0.34; 95%
confidence interval [CI], 0.29–0.40). Approximately 65% of all cases
and 81% of all controls had documented influenza immuniza-
tions during the combine influenza seasons. Of the 1221 with no
documented influenza immunization, 26 (2.1%) had documented
reasons for missing immunization; 15 (1.2%) received medical
exceptions (e.g., egg allergy), and 11 (0.9%) did not receive immu-
nization due to administrative orders (e.g., termination of military
service). Adjusted for immunization status, and the aforemen-
tioned covariates, males had a greater odds for a GAS-illness
diagnosis than females (aOR 1.28; 95% CI, 1.04–1.57). Age was also
an independent predictor for GAS-illness, with trainees younger
than 25 years demonstrating nearly twice the odds for a diagnosis
than those 30 years and older (aOR 1.62; 95% CI, 1.01–2.59).
4. Discussion
A strong protective effect was suggested for BCT influenza
immunization on the diagnosis of a GAS-illness, in a young and
healthy military population (aOR 0.34; 95% CI, 0.29–0.40). This
association was consistent across four recent influenza seasons.
The results suggest that influenza immunization may decrease
the odds of acquiring, and/or change the clinical expression
of, GAS infections during recruit training. Epidemiologic and
clinical interactions between influenza and bacterial respiratory
pathogens are well documented in the literature, suggesting bio-
logic plausibility for the measured beneficial effect of influenza
immunization on GAS-illness in the current study. However, due
to several study limitations, these findings must be interpreted
cautiously.
The case definition employed in the current study was based
on routinely kept medical surveillance records and thus the spe-
cific criteria for GAS diagnosis (i.e., clinical vs. laboratory) are
unknown. The lack of laboratory confirmation may raise concern
with regard to possible misclassification in that a clinician may
erroneously assign a GAS diagnosis based on clinical presenta-
tion rather than diagnostic test results [16]. However, previously
published work suggests that only a minority, ∼2%, of clinicians
use clinical criteria alone to diagnose GAS and this proportion
may be decreasing over time with the increasing availability
of highly sensitive, easy to use point-of-care tests (e.g., rapid
antigen-detection test) [17,18]. Furthermore, we do not expect clin-
icians to differentially diagnose GAS based on a trainee’s influenza
immunization status (i.e., exposure). The employment of routinely
reported medical administrative records (i.e., ICD-9-CM codes)
introduces the possibility of case-misclassification due to data
entry and miscoding errors. The use of routinely reported medical
administrative records also introduces the possibility of exposure
misclassification due to data entry andmiscoding errors in vaccine
administration. Furthermore, many of the other immunizations
administered at the start of recruit training may play a role in
the observed effect between influenza vaccine and GAS-related ill-
nesses. A high prevalence of unimmunized recruits (i.e., 11–47%)
was documented during the current study. Given that U.S. Army
policy dictates inoculation with the current year’s influenza vac-
cine to all non-allergic service members, the latter prevalence
may reflect incomplete or inaccuracies in reporting [19]. However,
the surveillance period corresponding to the ‘influenza season’
employed in the current study, September through April, may
have resulted in the capture of substantial numbers of recruits
who entered service after the ‘prior year’s’ influenza vaccine was
removed from use, but prior to the ‘next year’s’ vaccine hav-
ing become available. If these recruits had not been targeted
for ‘catch up’ with the current year’s vaccine, they would have
remained unimmunized against influenza throughout their BCT
period.
Another potential limitation in the interpretation of the results
of the current study is related to the ecologic nature of the BPG
prophylaxis assessment. BPG prophylaxis status was based on
installation policy, not on individual record. Therefore, true GAS-
illness cases may have been excluded from the study by the 30-day
latency case-definition criterion. Furthermore, tandemprophylaxis
with BPGnot only protects recipients fromacquiringGAS infections
during the first fewweeks of training but also prevents the seeding
of GAS strains into the recruit population. To the extent that recruit
camps are epidemiologically closed – hence, isolated from outside
sources of GAS – tandem prophylaxis would lower risk of strepto-
coccal illnesses during the entire basic training period. If trainees
who received influenza immunizations were more likely than oth-
ers to receiveBPG, then the apparent associationbetween influenza
immunization andGAS-related illnesses could reflect heprolonged,
population-level effects of tandem BPG prophylaxis [20]. How-
ever, there was no reason to have expected an association between
BPG prophylaxis and influenza immunization. Furthermore, it is
presumed that stratification by UIC would accommodate this asso-
ciation had it been extant.
In conclusion, the strong protective effect of Army trainee
influenza immunization on the odds of GAS-illness diagnosis,
measured in the current study, is bothbiologicallyplausible and rel-
evant to current clinical military practice. Many epidemiologic and
clinical interactions have been documented between respiratory
pathogens—including, for example, between influenza and GAS
[5,8]. Given this synergism among various pathogens, the effects
of agent-specific interventions may also be synergistic (i.e., greater
in scope and magnitude than preventing agent-specific diseases
alone) [8]. A prospective study with immunization status verifica-
tion and laboratory confirmedGAS-illness diagnosis is necessary to
validate or refute these findings.
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